LQDA compared with IRD: revenue, margins and what each company keeps, and the suppliers and customers both name

LQDALiquidia Corp

Mkt capRevenueRevenue

IRDOpus Genetics, Inc.

Mkt capRevenueRevenue

Compare

LQDALiquidia Corp

IRDOpus Genetics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

LQDA, solidIRD, dashed

Supply-chain overlap

Revenue flow

IRD: latest quarter is a loss; flow not drawable.Method ›

LQDALiquidia Corp

42.21▲+0.85%· post 42.21

Mkt cap$4.2BRevenue$172MQ2 FY26Revenue$158MFY25

IRDOpus Genetics, Inc.

3.96▲+7.03%· post 3.87

ClosedNov 3 '26

Mkt cap$327.0MRevenue$755,000Q2 FY26Revenue$14MFY25

Compare

ClosedNov 3 '26

LQDALiquidia Corp

IRDOpus Genetics, Inc.

42.21▲+0.85%post 42.21

Price

3.96▲+7.03%post 3.87

$4.2B

Mkt cap

$327.0M

Q2 FY26$172M

Revenue

$755,000Q2 FY26

FY25$158M

Revenue

$14MFY25

LQDA42.21▲+0.85%vsIRD3.96▲+7.03%ClosedNov 3 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LQDA 11

ICUIICU Medicalsupplier

GSKGlaxoSmithKlinesupplier

—LGM Pharmaunlistedsupplier

—Lonza Tampaunlistedsupplier

7 more · LQDA chain ›

Shared 0

No shared counterparties.

Only IRD 4

VTRSViatrissupplier

—FDA Office of Orphan Drug Productsunlistedsupplier

—Foundation Fighting Blindnessunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

National Institutes of Health

unlistedsupplier